» Articles » PMID: 35464488

Extracellular Vesicle Therapy for Type 1 Diabetes

Abstract

Type 1 diabetes (T1D) is a chronic disorder characterized by immune-mediated destruction of pancreatic insulin-producing β-cells. The primary treatment for T1D is multiple daily insulin injections to control blood sugar levels. Cell-free delivery packets with therapeutic properties, extracellular vesicles (EVs), mainly from stem cells, have recently gained considerable attention for disease treatments. EVs provide a great potential to treat T1D ascribed to their regenerative, anti-inflammatory, and immunomodulatory effects. Here, we summarize the latest EV applications for T1D treatment and highlight opportunities for further investigation.

Citing Articles

Could hypoxic conditioning augment the potential of mesenchymal stromal cell-derived extracellular vesicles as a treatment for type 1 diabetes?.

Forkan C, Shrestha A, Yu A, Chuang C, Pociot F, Yarani R Stem Cell Res Ther. 2025; 16(1):37.

PMID: 39901225 PMC: 11792614. DOI: 10.1186/s13287-025-04153-4.


The Potential of Mesenchymal Stem Cell-Derived Exosomes to Treat Diabetes Mellitus.

Kim J, Lee J, Cha G, Yoon J Biomimetics (Basel). 2025; 10(1).

PMID: 39851765 PMC: 11760843. DOI: 10.3390/biomimetics10010049.


Engineered extracellular vesicles as "supply vehicles" to alleviate type 1 diabetes.

Wang F, Li Z Extracell Vesicles Circ Nucl Acids. 2025; 5(4):718-721.

PMID: 39811729 PMC: 11725422. DOI: 10.20517/evcna.2024.61.


Beta-Cell-Derived Extracellular Vesicles: Mediators of Intercellular Communication in the Islet Microenvironment in Type 1 Diabetes.

Dekkers M, Pu X, Enciso-Martinez A, Zaldumbide A Cells. 2024; 13(23).

PMID: 39682744 PMC: 11640590. DOI: 10.3390/cells13231996.


Unleashing the potential of extracellular vesicles for ulcerative colitis and Crohn's disease therapy.

Njoku G, Forkan C, Soltysik F, Nejsum P, Pociot F, Yarani R Bioact Mater. 2024; 45:41-57.

PMID: 39610953 PMC: 11602541. DOI: 10.1016/j.bioactmat.2024.11.004.


References
1.
Mirza A, Kaur S, Nielsen L, Storling J, Yarani R, Roursgaard M . Breast Milk-Derived Extracellular Vesicles Enriched in Exosomes From Mothers With Type 1 Diabetes Contain Aberrant Levels of microRNAs. Front Immunol. 2019; 10:2543. PMC: 6823203. DOI: 10.3389/fimmu.2019.02543. View

2.
Mahdipour E, Salmasi Z, Sabeti N . Potential of stem cell-derived exosomes to regenerate β islets through Pdx-1 dependent mechanism in a rat model of type 1 diabetes. J Cell Physiol. 2019; 234(11):20310-20321. DOI: 10.1002/jcp.28631. View

3.
Bai C, Ren Q, Liu H, Li X, Guan W, Gao Y . miR-212/132-Enriched Extracellular Vesicles Promote Differentiation of Induced Pluripotent Stem Cells Into Pancreatic Beta Cells. Front Cell Dev Biol. 2021; 9:673231. PMC: 8155495. DOI: 10.3389/fcell.2021.673231. View

4.
Baekkeskov S, Hubbell J, Phelps E . Bioengineering strategies for inducing tolerance in autoimmune diabetes. Adv Drug Deliv Rev. 2017; 114:256-265. DOI: 10.1016/j.addr.2017.06.007. View

5.
Bobrie A, Colombo M, Raposo G, Thery C . Exosome secretion: molecular mechanisms and roles in immune responses. Traffic. 2011; 12(12):1659-68. DOI: 10.1111/j.1600-0854.2011.01225.x. View